J Cianciara
- Hepatology top 5%
- Epidemiology top 10%
- Infectious Diseases
- Molecular Biology
- Immunology
- Co-authors
- Tomasz LaskusMarek RadkowskiHugo E. VargasJorge RakelaJ SlusarczykW. J. BrzoskoAndrzej HorbanDF Gray
- Topics
- Hepatitis B Virus Studies (23 papers)Hepatitis C virus research (23 papers)Liver Disease Diagnosis and Treatment (20 papers)
- Partner nations
- PolandUnited StatesUnited Kingdom
In The Last Decade
J Cianciara
31 papers receiving 310 citations
Peers
Comparison fields: 5 of 46
- Hepatology 289
- Epidemiology 289
- Infectious Diseases 50
- Molecular Biology 18
- Immunology 18
Countries citing papers authored by J Cianciara
This map shows the geographic impact of J Cianciara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Cianciara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Cianciara more than expected).
Fields of papers citing papers by J Cianciara
This network shows the impact of papers produced by J Cianciara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Cianciara. The network helps show where J Cianciara may publish in the future.
Co-authorship network of co-authors of J Cianciara
This figure shows the co-authorship network connecting the top 25 collaborators of J Cianciara. A scholar is included among the top collaborators of J Cianciara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Cianciara. J Cianciara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 14 | |
| 3 | Efficacy of 6 months treatment with PEG-interferon alpha-2b plus ribavirin (P/R) in patients infected with hepatitis C with genotype 1 of low viral load (G1LVL) | 5 |
| 4 | 5 | |
| 5 | Sustained viral load and ALT reduction following 48 weeks of entecavir treatment in subjects with chronic hepatitis B who have failed lamivudine. | 21 |
| 6 | [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin]. | 8 |
| 7 | 5 | |
| 8 | 24 | |
| 9 | 4 | |
| 10 | 73 | |
| 11 | 11 | |
| 12 | [Markers of hepatitis A infection in drug addicts]. | 1 |
| 13 | 12 | |
| 14 | 25 | |
| 15 | [Occurrence of antibodies against hepatitis C virus (HCV) among drug addicts]. | 2 |
| 16 | Acute non-A, non-B hepatitis in a hospital population in Warsaw, Poland: clinical and epidemiological aspects. | 1 |
| 17 | 4 | |
| 18 | [Evaluation of the treatment of chronic active hepatitis (HBsAg+) with isoprinosine. II. Immunological studies]. | 1 |
| 19 | Exacerbation of chronic active hepatitis type B after short-term corticosteroid therapy resulting in fatal liver failure. | 16 |
| 20 | 0 |
About J Cianciara
J Cianciara is a scholar working on Hepatology, Epidemiology and Pharmacology, having authored 35 papers that have together received 328 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (23 papers), Hepatitis C virus research (23 papers) and Liver Disease Diagnosis and Treatment (20 papers). The work is most often cited by research in Hepatology (289 citations), Epidemiology (289 citations) and Infectious Diseases (50 citations). J Cianciara has collaborated with scholars based in Poland, United States and United Kingdom. Frequent co-authors include Tomasz Laskus, Marek Radkowski, Hugo E. Vargas, Jorge Rakela, J Slusarczyk, W. J. Brzosko, Andrzej Horban, DF Gray, Jenny Heathcote and Graham Farrell. Their work appears in journals such as Hepatology, The Journal of Infectious Diseases and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.